Biobanking in Research and Development

The global biobanking market has been experiencing significant growth in recent years. The market size and growth of the biobanking are expected to reach USD 136.9 billion by 2030, growing at an annual growth rate (CAGR) of around 8.6%.

Factors driving this growth include increasing demand for high quality biospecimens, advancements in biobanking technologies, and the growing prevalence of chronic and infectious diseases including public health emergencies. Increasing research and development activities in the field of genomics, personalized medicine, and drug discovery, have resulted in rising investments in biobanks by both public and private sectors.​

nXgen specializes in advancing biobanking in healthcare research initiatives by developing, managing, and optimizing biorepositories.

Clinical Research

Our expertise in clinical research enables us to provide comprehensive support for your research studies, from protocol design to regulatory compliance.

Healthcare Data Management​

We offer specialized solutions for healthcare data management using state -of the-art LIMS systems ensuring the security, integrity, and accessibility of your valuable research data.

Strategy and Planning

Our team provides strategic guidance and operational support for research, facilitating the discovery and development of life-changing therapies.

New Technologies


As leaders in biobanking consulting, we assist in the strategic development and implementation of latest innovations to drive advancements in healthcare.